Načítá se...
Synergy Between Two Chimeric Lysins to Kill Streptococcus pneumoniae
Phage lysins constitute a new generation of antimicrobials that are becoming a promising alternative and complementation to current antibiotic therapies, which are nowadays called into question by the increasing numbers of multiresistant bacteria. Streptococcus pneumoniae is a leading human pathogen...
Uloženo v:
| Vydáno v: | Front Microbiol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6560164/ https://ncbi.nlm.nih.gov/pubmed/31231338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2019.01251 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|